London · Delayed Price · Currency is GBP · Price in GBX Arecor Therapeutics Statistics
Total Valuation
AIM:AREC has a market cap or net worth of GBP 37.60 million. The enterprise value is 34.50 million.
| Market Cap | 37.60M |
| Enterprise Value | 34.50M |
Important Dates
The last earnings date was Monday, October 12, 2026.
| Earnings Date | Oct 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AIM:AREC has 45.30 million shares outstanding. The number of shares has increased by 11.97% in one year.
| Current Share Class | 45.30M |
| Shares Outstanding | 45.30M |
| Shares Change (YoY) | +11.97% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 14.14% |
| Owned by Institutions (%) | 35.42% |
| Float | 28.45M |
Valuation Ratios
The trailing PE ratio is 190.74.
| PE Ratio | 190.74 |
| Forward PE | n/a |
| PS Ratio | 40.72 |
| PB Ratio | 9.84 |
| P/TBV Ratio | 9.87 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 174.43 |
| EV / Sales | 37.24 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.69, with a Debt / Equity ratio of 0.02.
| Current Ratio | 4.69 |
| Quick Ratio | 4.29 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -639.25 |
Financial Efficiency
Return on equity (ROE) is -1.44% and return on invested capital (ROIC) is -872.70%.
| Return on Equity (ROE) | -1.44% |
| Return on Assets (ROA) | -64.57% |
| Return on Invested Capital (ROIC) | -872.70% |
| Return on Capital Employed (ROCE) | -137.21% |
| Weighted Average Cost of Capital (WACC) | 4.70% |
| Revenue Per Employee | 26,970 |
| Profits Per Employee | 5,758 |
| Employee Count | 33 |
| Asset Turnover | 0.18 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AIM:AREC has paid 26,000 in taxes.
| Income Tax | 26,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +7.10% in the last 52 weeks. The beta is 0.08, so AIM:AREC's price volatility has been lower than the market average.
| Beta (5Y) | 0.08 |
| 52-Week Price Change | +7.10% |
| 50-Day Moving Average | 73.68 |
| 200-Day Moving Average | 70.53 |
| Relative Strength Index (RSI) | 65.14 |
| Average Volume (20 Days) | 31,428 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AIM:AREC had revenue of GBP 890,000 and earned 190,000 in profits. Earnings per share was 0.01.
| Revenue | 890,000 |
| Gross Profit | 503,000 |
| Operating Income | -5.11M |
| Pretax Income | -21,000 |
| Net Income | 190,000 |
| EBITDA | -5.01M |
| EBIT | -5.11M |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
The company has 3.16 million in cash and 57,000 in debt, with a net cash position of 3.10 million or 0.07 per share.
| Cash & Cash Equivalents | 3.16M |
| Total Debt | 57,000 |
| Net Cash | 3.10M |
| Net Cash Per Share | 0.07 |
| Equity (Book Value) | 3.68M |
| Book Value Per Share | 0.10 |
| Working Capital | 3.40M |
Cash Flow
In the last 12 months, operating cash flow was -4.58 million and capital expenditures -36,000, giving a free cash flow of -4.61 million.
| Operating Cash Flow | -4.58M |
| Capital Expenditures | -36,000 |
| Depreciation & Amortization | 107,000 |
| Net Borrowing | -91,000 |
| Free Cash Flow | -4.61M |
| FCF Per Share | -0.10 |
Margins
Gross margin is 56.52%, with operating and profit margins of -574.61% and 21.35%.
| Gross Margin | 56.52% |
| Operating Margin | -574.61% |
| Pretax Margin | -2.36% |
| Profit Margin | 21.35% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AIM:AREC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -11.97% |
| Shareholder Yield | -11.97% |
| Earnings Yield | 0.52% |
| FCF Yield | -12.72% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for AIM:AREC is 250.50, which is 201.81% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 250.50 |
| Price Target Difference | 201.81% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AIM:AREC has an Altman Z-Score of -0.42 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.42 |
| Piotroski F-Score | 3 |